TOKYO--(BUSINESS WIRE)--LUCA Science (Tokyo, Japan), a biotechnology company pioneering a novel class of mitochondrial therapeutics, announced today that it will collaborate with the Division of Cardiology, Field of Internal Medicine, Nagoya University Graduate School of Medicine to initiate a joint research on the development of mitochondrial therapy for cardiac ischemicreperfusion injury. Continue reading →

This article was originally published here J Card Surg. Continue reading →

Among a series of 2,500 patients with mitral regurgitation (MR) treated with the MitraClip (Abbott) in the United States, nearly two-thirds had preexisting CAD, and this was associated with an increased risk of in-hospital acute myocardial infarction, a new analysis suggests. But patients who underwent PCI for their CAD during the same index hospitalization had higher in-hospital morbidity and mortality, write Kristina Gifft, DO (University of Missouri Hospital, Columbia), and colleagues in Catheterization and Cardiovascular Interventions this week. Continue reading →

This article was originally published here ESC Heart Fail. 2020 Dec 3 Continue reading →

This article was originally published here Am Heart J. Continue reading →

This article was originally published here Chin Med J (Engl). 2020 Dec 2. Continue reading →

This article was originally published here Ther Adv Cardiovasc Dis. 2020 Jan-Dec;14:1753944720977732 Continue reading →

Myocardial Infarction Drug used to treat Heart Attack. Medicines and chemical substances that can cause myocardial infarction. Continue reading →

This article was originally published here Cureus. Continue reading →

Lipid-lowering pharmacotherapy targeting low density lipoprotein- cholesterol (LDL-C) was found to be safe and effective in reducing cardiovascular (CV) and cerebrovascular events, with similar efficacy in older and younger patients, according to the results of a systematic review and meta-analysis published in The Lancet. Continue reading →